CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net income	$ 35,499	$ 43,377
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization, including patient equipment depreciation	284,421	274,797
Goodwill impairment	0	13,078
Equity-based compensation	16,738	10,614
Change in fair value of warrant liability	0	(1,800)
Reduction in the carrying amount of operating lease right-of-use assets	22,946	24,902
Reduction in the carrying amount of finance lease right-of-use assets	10,942	7,927
Deferred income tax expenses	47,167	18,664
Change in fair value of interest rate swaps, net of reclassification adjustment	0	(367)
Amortization of deferred financing costs	4,437	4,247
Loss on extinguishment of debt	0	2,273
Payment of contingent consideration from an acquisition	0	(1,850)
Gain on sale of businesses	(32,225)	0
Other	3,000	569
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	22,142	(12,305)
Inventory	(9,749)	(21,474)
Prepaid and other assets	(75,059)	23,656
Operating lease obligations	(23,474)	(25,212)
Operating liabilities	111,802	30,328
Net cash provided by operating activities	418,587	391,424
Cash flows from investing activities:
Purchases of equipment and other fixed assets	(278,492)	(228,719)
Payments for business acquisitions, net of cash acquired	(18,561)	0
Proceeds from the sale of businesses, net of cash disposed	117,175	0
Proceeds from the sale of assets	0	5,316
Receipt of contingent consideration from the sale of assets	1,156	0
Net cash used in investing activities	(178,722)	(223,403)
Cash flows from financing activities:
Repayments on long-term debt and lines of credit	(225,000)	(373,477)
Proceeds from borrowings on lines of credit	0	253,477
Repayments of finance lease obligations	(12,179)	(8,261)
Proceeds from the exercise of stock options	0	742
Proceeds received in connection with employee stock purchase plan	1,210	999
Payments relating to the Tax Receivable Agreement	(25,045)	(1,432)
Payments of debt financing costs	0	(6,429)
Distributions to noncontrolling interests	(5,426)	(3,500)
Payments for tax withholdings from vesting of restricted stock units	(2,604)	(1,794)
Payments of contingent consideration and deferred purchase price from acquisitions	(211)	(5,298)
Net cash used in financing activities	(269,255)	(144,973)
Net (decrease) increase in cash	(29,390)	23,048
Cash at beginning of period	109,747	77,132
Cash at end of period	80,357	100,180
Supplemental disclosures:
Cash paid for interest	95,999	112,519
Cash paid for income taxes, net of refunds	23,993	13,015
Noncash investing and financing activities:
Unpaid equipment and other fixed asset purchases at end of period	61,428	46,720
Assets subject to operating lease obligations	21,286	24,604
Operating lease obligations	(21,286)	(24,604)
Write-off of assets subject to operating lease obligations	(3,318)	(3,631)
Write-off of operating lease obligations	3,318	3,631
Assets subject to finance lease obligations	12,648	15,665
Finance lease obligations	(12,648)	(15,665)
Write-off of assets subject to finance lease obligations	(1,421)	(513)
Write-off of finance lease obligations	$ 1,421	$ 513